News

AAACN Launches Innovative Journal for Ambulatory Care Nursing

AAACN Launches Innovative Journal for Ambulatory Care Nursing

AAACN Introduces the Journal of Ambulatory Care Nursing

The American Academy of Ambulatory Care Nursing (AAACN) has marked a significant milestone by launching its inaugural issue of the Journal of Ambulatory Care Nursing (JACN). This scholarly, peer-reviewed publication is dedicated to enhancing the field of ambulatory nursing and represents a major step forward in supporting nursing professionals.

Designed to foster evidence-based practices, JACN aims to drive clinical research and professional development in the industry. The journey toward establishing this journal has been fueled by the passion and dedication of AAACN nursing leadership over many years.

Dr. Susan B. Fowler, the editor of JACN, expressed excitement about this new venture: "The Journal of Ambulatory Care Nursing has become a reality through the vision and efforts of AAACN nursing leadership. It's an honor to be the first editor, guiding the journey of this publication as it grows and develops in the upcoming years."

Accessing the Inaugural Issue

As part of its commitment to its members, the Quarter 1 2025 issue is currently available for free to all AAACN members. The issue is designed in a digital format that is easily accessible and offers professional development hours. This quarterly journal promotes collaboration, enhances collective knowledge, and encourages crucial discussions within the nursing community dedicated to ambulatory care.

Editorial Board Excellence

The formidable editorial board behind JACN includes esteemed figures from the nursing field. Alongside Dr. Fowler, members include:

  • Beth Ann Swan, PhD, CRNP, FAAN
  • Nancy May, DNP, AMB-BC, NEA-BC, FAAN
  • Kathy Mertens, DNP, MN, MPH, RN
  • Brandy Williamson, MSN, RN, CPN

Dr. Fowler further elaborated on the journal's purpose, stating, "This journal serves as a vital mechanism to disseminate scholarly work that is directly relevant to ambulatory care nursing. It will expand the knowledge base, stimulate research ideas, and support the dissemination of scholarship throughout the nursing community."

Highlighted Articles from the Inaugural Issue

The initial issue of JACN features a range of impactful articles, including:

  • Exploring the Primary Care Registered Nurse Role: Activities and Enhanced Practice Barriers, by Susan Watkins, Vicki Kowlowitz, Judy Neubrander, MyoungJin Kim, and Mary J. Dyck.
  • An Initiative to Implement Universal Pediatric Suicide Screenings: Research conducted by Kristin Kroll, Tera Bartelt, Margaret Ertz, and Jenny Walczak.
  • Implementation and Outcomes of a Telephonic Verbal Violence De-Escalation Process: Insights from Cara Spencer, June Fouse, Stephanie Storch-Goodyear, and Jennifer Rodgers.

For those who are not members, individual or institutional subscriptions to this invaluable resource are available for purchase. Accessing JACN provides patients and healthcare professionals alike with critical insights into the evolving world of ambulatory care nursing.

Mission and Commitment of AAACN

AAACN stands as a leader in advancing the role of nurses within the community and ambulatory care sectors. With a mission centered around Shaping Care Where Life Happens, the organization focuses on promoting holistic care and strengthens nurses' essential roles in enhancing national health.

Connect with AAACN

For more detailed information about the journal and its publications, interested individuals are encouraged to visit the AAACN website. Furthermore, media inquiries can be directed to Rebecca Klavens, the Communications & Media Relations Manager at AAACN, who is available to provide support and answer questions about this new initiative.

Frequently Asked Questions

What is the Journal of Ambulatory Care Nursing (JACN)?

JACN is a new scholarly, peer-reviewed journal introduced by the American Academy of Ambulatory Care Nursing, focusing on improving knowledge and practices in ambulatory care.

Who can access the JACN?

The JACN is accessible for free to AAACN members, while non-members can purchase individual or institutional subscriptions.

What topics will JACN cover?

The journal will publish articles on evidence-based practices, clinical research, and professional development in ambulatory care nursing.

Who is on the editorial board of JACN?

The editorial board features distinguished members such as Dr. Susan B. Fowler, Dr. Beth Ann Swan, Dr. Nancy May, Dr. Kathy Mertens, and Brandy Williamson.

How often will JACN be published?

The Journal of Ambulatory Care Nursing will be published quarterly, ensuring timely updates and resources for nursing professionals.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 16

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 18

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

AbolerIS Pharma Continues Innovating in Autoimmune Treatments

Updated Category News Views 190

AbolerIS Pharma's Innovative Approach to Autoimmune Disorders AbolerIS Pharma, a name making waves in the biopharmaceutical sector, is dedicated to transforming lives for those grappling with autoimmune and inflammatory diseases. The company's latest innovation, ABO21009, is a unique anti-CD45RC monoclonal antibody poised to address significant gaps in treatment for...

Continue Reading
Cellectis Faces Pressure After Allogene's Arbitration Win

Updated Category News Views 156

Recent Developments Impacting Cellectis Shares Shares of Cellectis S.A. (NASDAQ: CLLS) experienced a significant decline following a favorable arbitration outcome for Allogene Therapeutics Inc. (NASDAQ: ALLO). The arbitration decision concluded in favor of Allogene's partner, Servier, which was directly related to the CAR-T therapy cemacabtagene ansegedleucel, also known...

Continue Reading
CN Announces Exciting Dividend for Its Shareholders

Updated Category News Views 82

CN's Third-Quarter Dividend Announcement CN, recognized as a leader in rail transportation, has officially declared a quarterly dividend on its common shares outstanding. The Board of Directors has approved a dividend of eighty-eight and three-quarter cents (C$0.8875) per share. This dividend will reward shareholders for their trust and investment in the company. Details...

Continue Reading
Mplify's Global NaaS Event: Shaping the Future of Connectivity

Updated Category News Views 265

Mplify's Vision for the Future of NaaS Mplify, a prominent name in the networking world, is preparing to host the highly anticipated Global Network-as-a-Service Event (GNE) in November 2025. This event will bring together leading experts and innovators focused on transforming how businesses leverage Network-as-a-Service (NaaS) in the rapidly evolving digital landscape....

Continue Reading
Euroholdings Ltd's Q3 2025 Performance and Future Growth Plans

Updated Category News Views 115

Euroholdings Ltd's Q3 2025 Performance Overview Euroholdings Ltd (NASDAQ: EHLD), a prominent player in the container shipping sector, has recently published its financial results for the third quarter and nine-month period that ended September 30, 2025. With a mission to provide efficient seaborne transportation for containerized cargo, Euroholdings made substantial...

Continue Reading